Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 241 AL 255

Cellular senescence at the crossroads of inflammation and Alzheimer's disease

Guerrero A, De Strooper B, Arancibia-Cárcamo IL.

Trends Neurosci. 2021 Sep;44(9):714-727. doi: 10.1016/j.tins.2021.06.007. Epub 2021 Aug 5.

A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease

Mukhopadhyay S, Banerjee D.

J Alzheimers Dis. 2021;83(4):1537-1552. doi: 10.3233/JAD-215065.

Untangling huge literature to disinter genetic underpinnings of Alzheimer's Disease: A systematic review and meta-analysis

G N S HS, Marise VLP, Satish KS, Yergolkar AV, Krishnamurthy M, Ganesan Rajalekshmi S, Radhika K, Burri RR.

Ageing Res Rev. 2021 Nov;71:101421. doi: 10.1016/j.arr.2021.101421. Epub 2021 Aug 8.

Optimization of cerebral organoids: a more qualified model for Alzheimer's disease research

Bi FC, Yang XH, Cheng XY, Deng WB, Guo XL, Yang H, Wang Y, Li J, Yao Y.

Transl Neurodegener. 2021 Aug 9;10(1):27. doi: 10.1186/s40035-021-00252-3.

Inflammation and Alzheimer's Disease: Mechanisms and Therapeutic Implications by Natural Products

Rather MA, Khan A, Alshahrani S, Rashid H, Qadri M, Rashid S, Alsaffar RM, Kamal MA, Rehman MU.

Mediators Inflamm. 2021 Jul 31;2021:9982954. doi: 10.1155/2021/9982954. eCollection 2021.

Apoptotic Pathways and Alzheimer's Disease: Probing Therapeutic Potential

Sharma VK, Singh TG, Singh S, Garg N, Dhiman S.

Neurochem Res. 2021 Dec;46(12):3103-3122. doi: 10.1007/s11064-021-03418-7. Epub 2021 Aug 12.

Formaldehyde-Crosslinked Nontoxic Aβ Monomers to Form Toxic Aβ Dimers and Aggregates: Pathogenicity and Therapeutic Perspectives

Zhao H, Huang X, Tong Z.

ChemMedChem. 2021 Nov 19;16(22):3376-3390. doi: 10.1002/cmdc.202100428. Epub 2021 Sep 8.

The Structure Biology of Tau and Clue for Aggregation Inhibitor Design

Wang D, Huang X, Yan L, Zhou L, Yan C, Wu J, Su Z, Huang Y.

Protein J. 2021 Oct;40(5):656-668. doi: 10.1007/s10930-021-10017-6. Epub 2021 Aug 17.

Icariin ameliorate Alzheimer's disease by influencing SIRT1 and inhibiting Aβ cascade pathogenesis

Chuang Y, Van I, Zhao Y, Xu Y.

J Chem Neuroanat. 2021 Nov;117:102014. doi: 10.1016/j.jchemneu.2021.102014. Epub 2021 Aug 15.

Microbiota-gut-brain axis and Alzheimer's disease: Implications of the blood-brain barrier as an intervention target

Liu S, Gao J, Liu K, Zhang HL.

Mech Ageing Dev. 2021 Oct;199:111560. doi: 10.1016/j.mad.2021.111560. Epub 2021 Aug 16.

Masitinib for the treatment of Alzheimer's disease

Ettcheto M, Cano A, Sanchez-López E, Verdaguer E, Folch J, Auladell C, Camins A.

Neurodegener Dis Manag. 2021 Aug;11(4):263-276. doi: 10.2217/nmt-2021-0019. Epub 2021 Aug 20.

The pleiotropic roles of autophagy in Alzheimer's disease: From pathophysiology to therapy

Festa BP, Barbosa AD, Rob M, Rubinsztein DC.

Curr Opin Pharmacol. 2021 Oct;60:149-157. doi: 10.1016/j.coph.2021.07.011. Epub 2021 Aug 19.

Aducanumab and the Medicalization (Still) of Alzheimer's Disease: A Challenge to Measure and Act On What Matters

Fick DM.

J Gerontol Nurs. 2021 Sep;47(9):2-4. doi: 10.3928/00989134-20210806-01. Epub 2021 Sep 1.

Marine-Derived Compounds with Anti-Alzheimer's Disease Activities

Hafez Ghoran S, Kijjoa A.

Mar Drugs. 2021 Jul 24;19(8):410. doi: 10.3390/md19080410.

cAMP Compartmentalization in Cerebrovascular Endothelial Cells: New Therapeutic Opportunities in Alzheimer's Disease

Viña D, Seoane N, Vasquez EC, Campos-Toimil M.

Cells. 2021 Jul 31;10(8):1951. doi: 10.3390/cells10081951.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias